Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

US Patent 7662387 · Granted Feb 16, 2010

Estimated economic value: $10,325,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Periostin antibodies and methods of using the same2025
Universal immune receptor expressed by T cells for the targeting of diverse and 2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS22022
Anti-NTB-A antibodies and related compositions and methods2022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2021